One Chain Immunotherapeutics
@onechaintx
Followers
1K
Following
118
Media
118
Statuses
305
Spin-off company of the @Menendez_Lab, @CarrerasIJC & @icreacommunity, aiming to develop CAR-T candidates as a treatment for oncological diseases.
Joined September 2020
RT @Menendez_Lab: Thrilled to see our latest study published! 🚀. We present a novel dual immunotherapy approach for T-ALL. Huge thanks to….
link.springer.com
T cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy characterized by high rates of induction failure and relapse, and effective targeted immunotherapies are lacking. Despite...
0
12
0
RT @CataloniaHealth: 📢 JOB OFFER | Our member @onechaintx is looking for a Senior Grants and Project Manager 👉 #Jo….
0
2
0
First day of the #FestivalofBiologics in Basel! 🎉 .A key event for discussing the latest advancements in biologics and therapeutics. Our CEO, Stefanos Theoharis, will be speaking about our innovative #CART cell therapies and our vision for transforming #cancer treatment.🧬
1
1
2
💬Last Friday, we took part at the #CoffeeConnection event at @PCB_UB . Our CEO, @StefanosTheoharis talked about all our scientific advancements in #CARTtherapies.🧬.What a pleasure to connect with other innovative companies at this insightful event! 🙌
0
2
2
Today is #WorldCancerResearchDay!🎗️. Thank you to all researchers dedicated to advancing #cancer treatment for your unwavering commitment!💪. At OneChain Immunotherapeutics, we are proud to contribute through our groundbreaking #CART cell therapies �
0
0
2
Our research director, Víctor Manuel Díaz Cortés, presented a poster about the pre-clinical studies done to develop the #CARxALL clinical trial dedicated to treating cortical T-cell acute lymphoblastic leukemia (T-ALL) 👨🔬
0
0
3
Our CEO, Stefanos Theoaris, participated as a panellist, presenting our pipeline development and our allogeneic gamma delta T-cell platform, funded by the EIC Transition. 📈
1
0
0
📢 Today was the last day of the 9th CAR-TCR Summit, #CARTCR2024, in Boston, where some of our team members had the pleasure to participate and exchange valuable insights in the field of #CART #celltherapy. 🥳.
1
0
1
📢Exciting news! The 9th CAR-TCR Summit is happening from September 17-20th in Boston, USA. We'll be there discussing the achievements and future direction of #OneChainTherapeutics in #CART therapies and sharing updates on our CARxALL trial. Keep tuned for more! 🚀. 👇
0
0
1
📢 We will be attending the #AdvancedTherapiesEurope conference on September 10-12th in Estoril, Portugal. Our CEO will be sharing his expertise on the future of funding #ATMPs. Looking forward to 3 days of interesting discussions and meetings! 🎉. 👇
0
0
1
Back on track! 🚀. 🎉 We're thrilled to announce that OneChain Immunotherapeutics is featured in a new blog by the @ContraCancerEs, highlighting our innovative work in #CART immunotherapy for #leukemia 🔬. 👉 Read the full blog:
blog.contraelcancer.es
Descubre cómo desde Contra el Cáncer apoyamos la innovación de la inmunoterapia para la leucemia junto a OneChain Immunotherapeutics. ¡Entra ahora!
0
3
6
👩🔬 Our commitment to #CancerResearch and innovation never rests. Thank you for your support as we work toward a future where cancer is no longer life-threatening. 🙌.#Oncology #Biotech #CARTCellTherapies #Innovation.
0
0
0
🌟 Our mission at OneChain Immunotherapeutics continues strong, advancing four clinical-phase programs, including #CARTCellTherapies for leukemia, pioneering γδ T-cell therapies and dual CAR T strategies for glioblastoma. #Oncology #Biotech #Immunotherapy #CancerResearch.
1
0
1
🔬 Excited to share a @fundacionbotin article on our commitment to CAR T therapy and cancer treatment innovation! . 🔗 Read about our journey, project progress, and crucial funding
0
0
2
Kicking Off a Revolutionary Journey in Advanced Therapies! 🚀. On May 3rd, we hosted the kick-off meeting for the TransMisiones project at @PCB_UB . Excited to innovate with AI for next-gen therapies! 🌟 .More info:
0
3
6
📣 Milestone Achieved! We've treated the first patient in our CARxALL trial with our most avanced product, OC-1. This marks a significant step forward in the fight against cortical T-cell acute lymphoblastic #leukemia. More info here 👉
2
3
25
RT @contracancerINV: Su proyecto investiga la aplicación de inmunoterapia celular adoptiva con Car-T para la leucemia linfoblástica aguda T….
0
1
0
🔬@ContraCancerEs is leading efforts to convert research into solutions that enhance patients' quality of life. At #OneChain, we're proud to be part of this ecosystem by developing a #CARTtherapy for an aggressive leukemia subtype, thanks to AECC IMPACT grant.
Con motivo del #DíaMundialdelaCreatividadylaInnovación, te contamos qué es la innovación en la investigación en cáncer y la importancia que tiene para que los resultados lleguen al paciente .@SRGIDIBELL @idibell_cat @onechaintx.@MiWEndo @OniriaTx.
0
2
5
🌟 Exciting news at #OneChain! We warmly welcome Irene, a recent PhD in Cancer Immunotherapy from CIMA. Her innovative research will enhance our team's efforts in #CancerResearch. 💪. Welcome, Irene! Learn more about her and our team here:
0
2
1